Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 8 | 116848536 | intron variant | C/T | snv | 1.6E-02 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 8 | 116866452 | intron variant | C/T | snv | 0.21 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 8 | 116866452 | intron variant | C/T | snv | 0.21 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.882 | 0.080 | 8 | 116861572 | intron variant | G/A;C | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 8 | 116861572 | intron variant | G/A;C | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 8 | 116861572 | intron variant | G/A;C | snv |
|
0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.882 | 0.080 | 8 | 116861572 | intron variant | G/A;C | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 8 | 116867092 | intron variant | A/G | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 8 | 116867092 | intron variant | A/G | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 8 | 116867092 | intron variant | A/G | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 8 | 116867092 | intron variant | A/G | snv |
|
0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
1.000 | 8 | 116863196 | stop gained | T/A | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 0.040 | 8 | 116852070 | missense variant | G/A | snv | 4.0E-06 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.200 | 8 | 116854423 | missense variant | C/T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.200 | 8 | 116854423 | missense variant | C/T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 8 | 116854279 | missense variant | G/C | snv |
|
0.800 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 8 | 116847643 | missense variant | A/G | snv |
|
0.800 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 8 | 116847532 | missense variant | C/T | snv | 8.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.800 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 8 | 116847588 | missense variant | A/G | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 8 | 116854244 | splice donor variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 0.080 | 8 | 116846150 | 3 prime UTR variant | G/A | snv | 0.70 |
|
0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 8 | 116846150 | 3 prime UTR variant | G/A | snv | 0.70 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 8 | 116846150 | 3 prime UTR variant | G/A | snv | 0.70 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 8 | 116846150 | 3 prime UTR variant | G/A | snv | 0.70 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 8 | 116850687 | frameshift variant | -/G | delins |
|
0.700 | 1.000 | 1 | 2019 | 2019 |